What is the future for CSF biomarkers in the prediction of cognitive decline and Alzheimer’’s disease?

ISSN： 1745-509X

Source： Aging Health, Vol.4, Iss.3, 2008-06, pp. : 213-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuropsychological assessment of mild cognitive impairment/prodromal Alzheimer’’s disease

By Coen Robert F

Aging Health, Vol. 7, Iss. 1, 2011-02 ,pp. : 155-162

Future Medicine

Access to resources Recommend Favorite

Alzheimer’’s disease and the blood––brain barrier: past, present and future

By Bowman Gene L Quinn Joseph F

Aging Health, Vol. 4, Iss. 1, 2008-02 ,pp. : 47-57

Future Medicine

Access to resources Recommend Favorite

Genetic and Environmental Contributions to Cognitive Decline in Aging and Alzheimer's Disease

By Welsh-Bohmer Kathleen A. Plassman Brenda L. Hayden Kathleen M.

Annual Review of Gerontology and Geriatrics, Vol. 30, Iss. 1, 2010-11 ,pp. : 81-114

Springer Publishing Company

Access to resources Recommend Favorite

Glaucoma and Alzheimer’’s disease in the elderly

By Bizrah Mukhtar Guo Li Cordeiro Maria Francesca

Aging Health, Vol. 7, Iss. 5, 2011-10 ,pp. : 719-733

Future Medicine

Access to resources Recommend Favorite

Memantine in the treatment of Alzheimer’s disease

By Porsteinsson Anton P Cosman Kelly M

Aging Health, Vol. 2, Iss. 6, 2006-12 ,pp. : 891-904

Future Medicine

Access to resources Recommend Favorite